Ribociclib is a drug that targets CDK4 and CDK6 to treat breast cancer, specifically the types with HR and HER2 . It comes in 200 mg tablets, and you take 600 mg every day for 21 days out of every 28 days. Each blister pack has 63 tablets.
Ribociclib works by stopping cancer cells from moving through their growth cycle. It’s a targeted treatment that keeps CDK4 and CDK6 from doing their thing too much, these are key players in cell growth. CDK4 and CDK6 are super important for cells to divide and make new DNA during their growth phase.
When you block these proteins, the cells just pause, stopping the spread of the cancer. It usually goes hand-in-hand with other hormonal treatments for people with the HR and HER2 types of breast cancer.
Reviews
There are no reviews yet.